Macrophage-Inspired Fe3O4 Nanozymes with a Hydrophobic Spiky Topography for Treating Drug-Resistant Bacteria
Fe3O4, the first reported nanozyme and the first FDA-approved transition-metal-based nanomaterial, holds promise for antibacterial therapy but is limited by poor ROS catalytic activity and utilization. Inspired by macrophage-like bacterial capture and insect wing micro/nanostructures, we designed Fe3O4 nanoparticles...